Literature DB >> 11419024

Tumor markers: should we or shouldn't we?

N J McCarthy1, S M Swain.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11419024

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


× No keyword cloud information.
  4 in total

1.  DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCER.

Authors:  Ankur Shah; Harpreet Singh; Vibhu Sachdev; James Lee; Sohiya Yotsukura; Ravi Salgia; Ajit Bharti
Journal:  Curr Proteomics       Date:  2010-04-01       Impact factor: 0.837

Review 2.  Promoting quality and evidence-based care in early-stage breast cancer follow-up.

Authors:  N Lynn Henry; Lynn N Henry; Daniel F Hayes; Scott D Ramsey; Gabriel N Hortobagyi; William E Barlow; Julie R Gralow
Journal:  J Natl Cancer Inst       Date:  2014-03-13       Impact factor: 13.506

3.  Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.

Authors:  April Scott; Ravi Salgia
Journal:  Biomark Med       Date:  2008-12-01       Impact factor: 2.851

4.  A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma.

Authors:  Koji Ueda; Naomi Saichi; Sachiko Takami; Daechun Kang; Atsuhiko Toyama; Yataro Daigo; Nobuhisa Ishikawa; Nobuoki Kohno; Kenji Tamura; Taro Shuin; Masato Nakayama; Taka-Aki Sato; Yusuke Nakamura; Hidewaki Nakagawa
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.